Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Galactomannan detection for invasive aspergillosis in immunocompromised patients.

Leeflang MM, Debets-Ossenkopp YJ, Wang J, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, Reitsma JB, Zhang M, Bossuyt PM, Vandenbroucke-Grauls CM.

Cochrane Database Syst Rev. 2015 Dec 30;(12):CD007394. doi: 10.1002/14651858.CD007394.pub2. Review.

PMID:
26716951
2.

Galactomannan detection for invasive aspergillosis in immunocompromized patients.

Leeflang MM, Debets-Ossenkopp YJ, Visser CE, Scholten RJ, Hooft L, Bijlmer HA, Reitsma JB, Bossuyt PM, Vandenbroucke-Grauls CM.

Cochrane Database Syst Rev. 2008 Oct 8;(4):CD007394. doi: 10.1002/14651858.CD007394. Review. Update in: Cochrane Database Syst Rev. 2015;12:CD007394.

PMID:
18843747
3.

Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.

Cruciani M, Mengoli C, Loeffler J, Donnelly P, Barnes R, Jones BL, Klingspor L, Morton O, Maertens J.

Cochrane Database Syst Rev. 2015 Oct 1;(10):CD009551. doi: 10.1002/14651858.CD009551.pub3. Review.

PMID:
26424726
4.

Polymerase chain reaction blood tests for the diagnosis of invasive aspergillosis in immunocompromised people.

Cruciani M, Mengoli C, Loeffler J, Donnelly P, Barnes R, Jones BL, Klingspor L, Morton O, Maertens J.

Cochrane Database Syst Rev. 2015 Sep 7;(9):CD009551. doi: 10.1002/14651858.CD009551.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;(10):CD009551.

PMID:
26343815
5.

Blood biomarkers for the non-invasive diagnosis of endometriosis.

Nisenblat V, Bossuyt PM, Shaikh R, Farquhar C, Jordan V, Scheffers CS, Mol BW, Johnson N, Hull ML.

Cochrane Database Syst Rev. 2016 May 1;(5):CD012179. doi: 10.1002/14651858.CD012179. Review.

PMID:
27132058
6.

Serum galactomannan levels in the diagnosis of invasive aspergillosis.

Okuturlar Y, Ozkalemkas F, Ener B, Serin SO, Kazak E, Ozcelik T, Ozkocaman V, Ozkan HA, Akalin H, Gunaldi M, Ali R.

Korean J Intern Med. 2015 Nov;30(6):899-905. doi: 10.3904/kjim.2015.30.6.899. Epub 2015 Oct 30.

7.

[Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].

Rácil Z, Kocmanová I, Weinbergerová B, Winterová J, Lengerová M, Hrncírová K, Mayer J.

Klin Mikrobiol Infekc Lek. 2009 Apr;15(2):48-57. Czech.

PMID:
19488961
8.

Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis.

Pfeiffer CD, Fine JP, Safdar N.

Clin Infect Dis. 2006 May 15;42(10):1417-27. Epub 2006 Apr 14.

PMID:
16619154
9.

[Value of serum galactomannan assay in the diagnosis of pediatric invasive pulmonary aspergillosis].

Zhang XY, Zhao SY, Jiang ZF.

Zhonghua Er Ke Za Zhi. 2009 Feb;47(2):83-6. Chinese.

PMID:
19573449
10.

Galactomannan antigen enzyme-linked immunosorbent assay for diagnosis of invasive aspergillosis after hematopoietic stem cell transplantation.

Foy PC, van Burik JA, Weisdorf DJ.

Biol Blood Marrow Transplant. 2007 Apr;13(4):440-3. Epub 2007 Feb 1.

11.

[A systematic review of the accuracy of diagnostic test of serum galactomannan antigen detection for invasive aspergillosis].

Sun WK, Zhang F, Xu XY, Shen YY, Shi Y.

Zhonghua Jie He He Hu Xi Za Zhi. 2010 Oct;33(10):758-65. Review. Chinese.

PMID:
21176508
12.

Galactomannan antigenemia in pediatric oncology patients with invasive aspergillosis.

Hayden R, Pounds S, Knapp K, Petraitiene R, Schaufele RL, Sein T, Walsh TJ.

Pediatr Infect Dis J. 2008 Sep;27(9):815-9. doi: 10.1097/INF.0b013e31817197ab.

PMID:
18703991
13.

Combination of the non-invasive tests for the diagnosis of endometriosis.

Nisenblat V, Prentice L, Bossuyt PM, Farquhar C, Hull ML, Johnson N.

Cochrane Database Syst Rev. 2016 Jul 13;7:CD012281. doi: 10.1002/14651858.CD012281. Review.

PMID:
27405583
14.

Galactomannan antigenemia for the diagnosis of invasive aspergillosis in neutropenic patients with hematological disorders.

Suankratay C, Kanitcharaskul P, Arunyingmongkol K.

J Med Assoc Thai. 2006 Nov;89(11):1851-8.

PMID:
17205865
15.

[Usefulness of galactomannan detection in the diagnosis and follow-up of hematological patients with invasive aspergillosis].

Moragues MD, Amutio E, García-Ruiz JC, Pontón J.

Rev Iberoam Micol. 2003 Sep;20(3):103-10. Review. Spanish.

16.

Prospective sandwich enzyme-linked immunosorbent assay for serum galactomannan: early predictive value and clinical use in invasive aspergillosis.

Rohrlich P, Sarfati J, Mariani P, Duval M, Carol A, Saint-Martin C, Bingen E, Latge JP, Vilmer E.

Pediatr Infect Dis J. 1996 Mar;15(3):232-7.

PMID:
8852911
17.

Evaluation of serum galactomannan enzyme immunoassay at two different cut-offs for the diagnosis of invasive aspergillosis in patients with febrile neutropenia.

Mohindra R, Capoor MR, Puri S, Raheja H, Gupta DK, Gupta B, Chowdhury R.

Indian J Med Microbiol. 2017 Apr-Jun;35(2):237-242. doi: 10.4103/ijmm.IJMM_17_47.

18.

[Value of Aspergillus galactomannan antigen detection in the diagnosis and follow-up of invasive aspergillosis in hematological patients].

Jarque I, Andreu R, Salavert M, Gómez D, Pemán J, Gobernado M, Sanz MA.

Rev Iberoam Micol. 2003 Sep;20(3):116-8. Spanish.

19.
20.

Prospective clinical evaluation of lower cut-offs for galactomannan detection in adult neutropenic cancer patients and haematological stem cell transplant recipients.

Maertens J, Theunissen K, Verbeken E, Lagrou K, Verhaegen J, Boogaerts M, Eldere JV.

Br J Haematol. 2004 Sep;126(6):852-60.

PMID:
15352990

Supplemental Content

Support Center